CONTRIBUTION OF ALPHA-INTERFERON (ALPHA-IFN) TO HIV-INDUCED IMMUNOSUPPRESSION

被引:0
|
作者
LACHGAR, A
BIZZINI, B
机构
关键词
HIV INFECTION; IMMUNOSUPPRESSION; ALPHA INTERFERON; INACTIVATION;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In the present investigation we have shown that PBLs taken from HIV-positive patients suppressed T-cell proliferation when cultured for at least 12 days. When infected In vitro with HIV-1, these cells become suppressive after 6 days. PBLs collected from seronegative individuals turned out to be non-suppressive even after prolonged culturing. However, when infected in vitro with HIV they were found to be cytostatic also after 6 days. This anti-immune activity, related to HIV infection, is mediated, at least in part, by alpha IFN, since about 50% of this HIV associated activity could be quenched by alpha IFN antibodies. We also showed that this T-cell cytostasis is associated with CD8(+) cells. In view of a possible use of suppressive cells for T-cell vaccination, we verified that such cellular functions were abolished by aldehyde treatment.
引用
收藏
页码:431 / 437
页数:7
相关论文
共 50 条
  • [21] THE EFFECT OF ENHANCERS ON THE BUCCAL ABSORPTION OF HYBRID (BDBB) ALPHA-INTERFERON
    STEWARD, A
    BAYLEY, DL
    HOWES, C
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1994, 104 (02) : 145 - 149
  • [22] HISTOLOGICAL BEHAVIOR OF CHRONIC HEPATITIS IN PATIENTS TREATED WITH ALPHA-INTERFERON
    VILLARI, D
    RAIMONDO, G
    FRENI, MA
    RODINO, G
    AIELLO, A
    FAVA, A
    LONGO, G
    BATOLO, D
    PATHOLOGY, 1992, 24 (04) : 243 - 246
  • [23] NEW POLYMERIC HYDROGEL FORMULATIONS FOR THE CONTROLLED RELEASE OF ALPHA-INTERFERON
    CHIELLINI, E
    SOLARO, R
    LEONARDI, G
    GIANNASI, D
    LISCIANI, R
    MAZZANTI, G
    JOURNAL OF CONTROLLED RELEASE, 1992, 22 (03) : 273 - 282
  • [24] TOPICAL AND SUBCUTANEOUS ALPHA-INTERFERON FAILS TO SUPPRESS CORNEAL NEOVASCULARIZATION
    NGUYEN, N
    GOLDBERG, M
    PICO, J
    KIM, W
    ABBOTT, RL
    LEVY, B
    CORNEA, 1995, 14 (02) : 147 - 151
  • [25] CISPLATIN AND RECOMBINANT ALPHA-INTERFERON IN ADVANCED BREAST-CANCER
    PRONZATO, P
    BERTELLI, G
    AMOROSO, D
    GOZZA, A
    ZANIBONI, A
    MARINI, G
    ROSSO, R
    ANNALS OF ONCOLOGY, 1990, 1 (02) : 150 - 151
  • [26] Serum alpha-interferon in lower respiratory tract infections of children
    Moulin, F
    Raymond, J
    Iniguez, JL
    Ravilly, S
    Lebon, P
    Gendrel, D
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1996, 15 (10) : 883 - 886
  • [27] SERUM ALPHA-INTERFERON IN CHILDREN WITH RIGHT ILIAC FOSSA PAIN
    CHIA, YW
    CARACHI, R
    ARMSTRONG, AA
    MCGARRY, GW
    CARRINGTON, D
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 1993, 86 (05) : 259 - 260
  • [28] Effects of alpha-interferon on serum beta-2-microglobulin
    Remes, K
    Tienhaara, A
    Pelliniemi, TT
    LEUKEMIA & LYMPHOMA, 1996, 21 (3-4) : 233 - 238
  • [29] Survival prolongation in HIV-associated progressive multifocal leukoencephalopathy treated with alpha-Interferon: an observational study
    Huang, SS
    Skolasky, RL
    Dal Pan, GJ
    Royal, W
    McArthur, JC
    JOURNAL OF NEUROVIROLOGY, 1998, 4 (03) : 324 - 332
  • [30] Combination alpha-interferon and lamivndine therapy for alpha-interferon-resistant chronic hepatitis B infection: results of a pilot study
    Mutimer, D
    Naoumov, N
    Honkoop, P
    Marinos, G
    Ahmed, M
    de Man, R
    McPhillips, P
    Johnson, M
    Williams, R
    Elias, E
    Schalm, S
    JOURNAL OF HEPATOLOGY, 1998, 28 (06) : 923 - 929